Cystic fibrosis or mucoviscidosis is a genetically passed on disease that makes it difficult for the recipient/patient to breathe freely. The recent research performed on rectifying this disease have given way to the use of an unconventional procedure that aids in the process of transportation of mutant proteins to the surface of lung lining. The tools used for inducing this effect are known as CFTR correctors. The experiments conducted on mice with CFTR correctors revealed that 60% rectification in the case of cystic fibrosis was achieved within 3 months. Scientists are keeping their hope in CFTR correctors for the rectification of many other human genetic diseases.